SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma surges despite reporting 53.56% fall in Q4 net profit

11 May 2012 Evaluate

Bal Pharma is currently trading at Rs. 20.00, up by 0.75 points or 3.90% from its previous closing of Rs. 19.25 on the BSE.

The scrip opened at Rs. 22.00 and has touched a high and low of Rs. 22.00 and Rs. 20.00 respectively. So far 1004 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 33.70 on 19-May-2011 and a 52 week low of Rs. 15.50 on 23-Dec-2011.

Last one week high and low of the scrip stood at Rs. 22.00 and Rs. 19.05 respectively. The current market cap of the company is Rs. 21.15 crore.

The promoters holding in the company stood at 51.46% while Institutions and Non-Institutions held 0.02% and 48.52% respectively. 

Bal Pharma has reported results for fourth quarter ended March 31, 2012.

The company has posted a fall of 53.56% in its net profit at Rs 1.63 crore for the quarter ended March 31, 2012 as compared to Rs 3.51 crore for the same quarter in the previous year.  However, total income has increased by 4.54% at Rs 39.67crore for quarter under review as compared Rs 37.95 crore for the quarter ended March 31, 2011.

Bal Pharma Share Price

77.19 0.00 (0.00%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.20
Dr. Reddys Lab 1209.85
Cipla 1224.00
Zydus Lifesciences 924.65
Lupin 2288.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×